Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Topical Sirolimus

Known as: Rapamune Topical Formulation 
A topical formulation containing the macrolide sirolimus (rapamycin), which is produced by the organism Streptomyces hygroscopicus, with potential… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
We used a topical formulation of sirolimus for treating port wine stain (PWS). Although pulsed dye laser (PDL) is the current… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Importance Inhibitors of mammalian target of rapamycin complex 1, such as sirolimus, effectively target skin lesions in tuberous… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2017
2017
Background: Data on long‐term topical sirolimus treatment of the cutaneous manifestations of tuberous sclerosis complex are rare… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Background: The skin is one of the most affected organs in tuberous sclerosis complex and angiofibromas are seen in almost 80% of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
BACKGROUND AND OBJECTIVE A port wine stain (PWS) is a type of capillary vascular malformation composed of malformed, dilated… Expand
Is this relevant?
2015
2015
Facial angiofibromas are the most visible and unsightly of all the cutaneous manifestations of tuberous sclerosis (TSC). A 17… Expand
Is this relevant?
2013
2013
BACKGROUND AND OBJECTIVE The angiofibromas of Tuberous sclerosis (TS) is well described manifestation. Due to the progressive… Expand
Is this relevant?
2012
2012
BACKGROUND Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous disorder characterized by the development of… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Systemically administered sirolimus has demonstrated efficacy in psoriasis in a multicentre European study… Expand
Is this relevant?